How to Buy rossari Shares on Fincept?
You can buy Rossari Biotech Limited shares on Different Brokers & Banks by creating an account and completing KYC verification online.
NSE: Rossari Biotech Limited Share Price Today, Share Analysis, Latest Updates & Insights | Fincept
Stay informed with the latest announcements for Rossari, including updates on board meetings and corporate actions.
Rossari Biotech Limited - https://www.rossari.com
Rossari Biotech Limited engages in manufacture and sale of specialty chemicals in India and internationally. It offers soap and detergents; inks, paints, and coatings; ceramics and tiles; pulp and papers; cement; performance additives; and water treatment solutions. The company also provides textile specialty chemicals, such as cotton, polyester, acrylic, wool, silk, nylon, functional finishes, denim, printing, and sustainable solutions; and pet grooming products, which include natural pet shampoos, powders, deodorants, sprays, creams, and floor washing liquids under the Lozalo, Hunger Fills, and Sniffy brand names. In addition, it provides poultry nutrition products comprising vitamin-mineral formulations, toxin binders, individual and cocktail enzymes, liquid nutraceuticals, and supplements or herbal preparations. The company was formerly known as Rossari Labtech and changed its name to Rossari Biotech Limited in December 2003. The company was founded in 1997 and is based in Mumbai, India.
Rossari Biotech Limited Share Price Today
719.90
OPEN
730.40
HIGH
708.90
LOW
711.55
CLOSE
34 K
VOLUME
4,368 Cr
Market Cap
63017
Average Volume
Basic Materials
Sector
NSI
Exchange
Rossari Biotech Limited Share Analysis & 2025 Insights
Investor Presentations
| Date | Description | Download |
|---|
SIP
Lumpsum
Invested Amount: ₹
Estimated Returns: ₹
Total Value: ₹
NSE: ROSSARI Stock Actions
Company |
Symbol |
ISIN |
Subject |
Ex Date |
Face Value |
Broadcast Date |
|---|---|---|---|---|---|---|
Rossari Biotech Limited |
ROSSARI |
INE02A801020 |
Extra Ordinary General Meeting |
04 Nov 2024 |
2 |
N/A |
Rossari Biotech Limited |
ROSSARI |
INE02A801020 |
Annual General Meeting/Dividend - Re 0.50 Per Share |
16 Aug 2024 |
2 |
N/A |
Rossari Biotech Limited |
ROSSARI |
INE02A801020 |
Annual General Meeting/Dividend - Re 0.50 Per Share |
24 May 2023 |
2 |
N/A |
Rossari Biotech Limited |
ROSSARI |
INE02A801020 |
Annual General Meeting/Dividend - Rs 0.50 Per Share |
07 Jul 2022 |
2 |
N/A |
Rossari Biotech Limited |
ROSSARI |
INE02A801020 |
Annual General Meeting/Dividend - Rs 0.50 Per Share |
08 Sep 2021 |
2 |
N/A |
NSE: ROSSARI Recent Announcements
Symbol |
Date |
Description |
Industry |
|---|---|---|---|
ROSSARI |
31 Dec 2024, 20:29:05 |
Updates |
N/A |
ROSSARI |
27 Dec 2024, 18:49:20 |
Trading Window-XBRL |
N/A |
ROSSARI |
27 Dec 2024, 18:47:11 |
Trading Window |
N/A |
ROSSARI |
25 Dec 2024, 00:04:54 |
Incorporation-XBRL |
N/A |
ROSSARI |
24 Dec 2024, 23:54:47 |
General Updates |
N/A |
NSE: ROSSARI Corporate Governance
Name |
Symbol |
Timestamp |
Submission Date |
XBRL Document |
|---|---|---|---|---|
Rossari Biotech Limited |
ROSSARI |
18 Oct 2024, 19:20:00 |
18 Oct 2024, 19:20:00 |
|
Rossari Biotech Limited |
ROSSARI |
09 Jul 2024, 14:52:00 |
09 Jul 2024, 14:52:00 |
|
Rossari Biotech Limited |
ROSSARI |
15 May 2024, 10:01:00 |
15 May 2024, 10:01:00 |
|
Rossari Biotech Limited |
ROSSARI |
10 Jan 2024, 20:00:00 |
10 Jan 2024, 20:30:00 |
|
Rossari Biotech Limited |
ROSSARI |
09 Oct 2023, 20:01:00 |
09 Oct 2023, 20:30:00 |
NSE: ROSSARI Detailed Governance
Category |
Date of Birth |
Date of Initial Appointment |
DIN |
Director Name |
Status |
|---|---|---|---|---|---|
Chairperson Related To Promoters,Executive Director |
31 Oct 1960 |
10 Aug 2009 |
00149205 |
Edward Menezes |
Active |
Executive Director-MD |
05 Dec 1965 |
10 Aug 2009 |
00149083 |
Sunil Srinivasan Chari |
Active |
Independent Director |
07 Apr 1970 |
12 Nov 2019 |
01761455 |
Aseem Dhru |
Active |
Independent Director |
30 Jul 1960 |
12 Nov 2019 |
08577249 |
Sharabh Pachory |
Active |
Independent Director |
03 Sep 1973 |
29 Apr 2023 |
07132341 |
Aparna Sharma |
Active |
NSE: ROSSARI Board Meetings
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
|---|---|---|---|---|---|
ROSSARI BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 19-Oct-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2024 . |
ROSSARI |
N/A |
INE02A801020 |
Rossari Biotech Limited |
11 Oct 2024, 18:19:25 |
Financial Results |
ROSSARI |
N/A |
INE02A801020 |
Rossari Biotech Limited |
12 Jul 2024, 19:47:45 |
Financial Results/Dividend |
ROSSARI |
N/A |
INE02A801020 |
Rossari Biotech Limited |
20 Apr 2024, 19:27:02 |
ROSSARI BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 20-Jan-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2023 . |
ROSSARI |
N/A |
INE02A801020 |
Rossari Biotech Limited |
12 Jan 2024, 20:05:02 |
ROSSARI BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 21-Oct-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2023 . |
ROSSARI |
N/A |
INE02A801020 |
Rossari Biotech Limited |
13 Oct 2023, 20:28:02 |
NSE: ROSSARI Event Calendar
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
Description |
|---|---|---|---|---|---|---|
Financial Results |
ROSSARI |
- |
INE02A801020 |
Rossari Biotech Limited |
11 Oct 2024, 00:00:00 |
To consider and approve the Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30, 2024 |
Financial Results |
ROSSARI |
- |
INE02A801020 |
Rossari Biotech Limited |
12 Jul 2024, 00:00:00 |
ROSSARI BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 20-July-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the quarter ended June 30 2024 |
Financial Results/Dividend |
ROSSARI |
- |
INE02A801020 |
Rossari Biotech Limited |
20 Apr 2024, 00:00:00 |
To consider and approve the financial results for the period ended March 31, 2024 and dividend |
Financial Results |
ROSSARI |
- |
INE02A801020 |
Rossari Biotech Limited |
12 Jan 2024, 00:00:00 |
Rossari Biotech Limited has informed NSE that the meeting of the Board of Directors of the Company is scheduled to be held on January 20, 2024 inter alia, to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2023. |
Financial Results |
ROSSARI |
- |
INE02A801020 |
Rossari Biotech Limited |
13 Oct 2023, 00:00:00 |
Meeting of the Board of Directors of the Company is scheduled on October 21, 2023, inter alia, to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter and half ended September 30, 2023. |
NSE: ROSSARI Balance Sheet Data In (Cr)
| date | period_type | Ordinary Shares Number | Share Issued | Net Debt | Total Debt | Tangible Book Value | Invested Capital | Working Capital | Net Tangible Assets | Capital Lease Obligations | Common Stock Equity | Total Capitalization | Total Equity Gross Minority Interest | Minority Interest | Stockholders Equity | Other Equity Interest | Retained Earnings | Additional Paid In Capital | Capital Stock | Common Stock | Total Liabilities Net Minority Interest | Total Non Current Liabilities Net Minority Interest | Other Non Current Liabilities | Non Current Pension And Other Postretirement Benefit Plans | Non Current Deferred Taxes Liabilities | Long Term Debt And Capital Lease Obligation | Long Term Capital Lease Obligation | Long Term Debt | Long Term Provisions | Current Liabilities | Other Current Liabilities | Current Deferred Taxes Liabilities | Current Debt And Capital Lease Obligation | Current Capital Lease Obligation | Current Debt | Pensionand Other Post Retirement Benefit Plans Current | Current Provisions | Payables | Other Payable | Total Tax Payable | Accounts Payable | Total Assets | Total Non Current Assets | Other Non Current Assets | Non Current Prepaid Assets | Non Current Deferred Taxes Assets | Other Investments | Investmentin Financial Assets | Available For Sale Securities | Financial Assets Designatedas Fair Value Through Profitor Loss | Long Term Equity Investment | Investmentsin Joint Venturesat Cost | Investmentsin Associatesat Cost | Goodwill And Other Intangible Assets | Other Intangible Assets | Goodwill | Net PPE | Accumulated Depreciation | Gross PPE | Construction In Progress | Other Properties | Machinery Furniture Equipment | Buildings And Improvements | Land And Improvements | Properties | Current Assets | Other Current Assets | Assets Held For Sale Current | Restricted Cash | Prepaid Assets | Inventory | Other Inventories | Finished Goods | Work In Process | Raw Materials | Other Receivables | Accounts Receivable | Allowance For Doubtful Accounts Receivable | Gross Accounts Receivable | Cash Cash Equivalents And Short Term Investments | Other Short Term Investments | Cash And Cash Equivalents | Cash Equivalents | Cash Financial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30T00:00:00 | quarterly | 55,289,266.00 | 55,289,266.00 | 1,234,780,000.00 | 1,607,810,000.00 | 8,623,360,000.00 | 12,606,380,000.00 | 4,865,250,000.00 | 8,623,360,000.00 | 178,450,000.00 | 11,177,020,000.00 | 11,918,170,000.00 | 11,177,020,000.00 | 0.00 | 11,177,020,000.00 | 11,066,440,000.00 | 0.00 | 0.00 | 110,580,000.00 | 110,580,000.00 | 5,933,980,000.00 | 1,423,200,000.00 | 0.00 | 0.00 | 485,150,000.00 | 891,050,000.00 | 149,900,000.00 | 741,150,000.00 | 47,000,000.00 | 4,510,780,000.00 | 168,000,000.00 | 0.00 | 716,760,000.00 | 28,550,000.00 | 688,210,000.00 | 0.00 | 51,010,000.00 | 2,413,600,000.00 | 0.00 | 117,500,000.00 | 2,296,100,000.00 | 17,111,000,000.00 | 7,734,970,000.00 | 600,200,000.00 | 0.00 | 72,140,000.00 | 0.00 | 44,030,000.00 | 44,030,000.00 | 0.00 | 257,140,000.00 | 0.00 | 0.00 | 2,553,660,000.00 | 1,366,550,000.00 | 1,187,110,000.00 | 4,140,890,000.00 | 0.00 | 4,140,890,000.00 | 984,220,000.00 | 3,156,670,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9,376,030,000.00 | 901,610,000.00 | 0.00 | 0.00 | 0.00 | 3,275,380,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8,630,000.00 | 4,348,110,000.00 | 0.00 | 0.00 | 842,300,000.00 | 647,720,000.00 | 194,580,000.00 | 0.00 | 0.00 |
| 2024-03-31T00:00:00 | quarterly | 55,245,966.00 | 55,245,966.00 | 806,570,000.00 | 1,187,920,000.00 | 7,848,660,000.00 | 11,535,550,000.00 | 4,188,380,000.00 | 7,848,660,000.00 | 129,650,000.00 | 10,477,280,000.00 | 10,810,520,000.00 | 10,477,280,000.00 | 0.00 | 10,477,280,000.00 | 35,360,000.00 | 5,645,160,000.00 | 4,686,270,000.00 | 110,490,000.00 | 110,490,000.00 | 5,244,230,000.00 | 996,860,000.00 | 0.00 | 39,840,000.00 | 514,720,000.00 | 442,300,000.00 | 109,060,000.00 | 333,240,000.00 | 39,840,000.00 | 4,247,370,000.00 | 897,690,000.00 | 101,010,000.00 | 745,620,000.00 | 20,590,000.00 | 725,030,000.00 | 49,750,000.00 | 45,230,000.00 | 2,267,200,000.00 | 57,400,000.00 | 18,840,000.00 | 2,190,960,000.00 | 15,721,510,000.00 | 7,285,760,000.00 | 30,000.00 | 92,120,000.00 | 48,100,000.00 | 0.00 | 2,250,000.00 | 120,000.00 | 2,130,000.00 | 250,680,000.00 | 166,680,000.00 | 84,000,000.00 | 2,628,620,000.00 | 1,441,510,000.00 | 1,187,110,000.00 | 4,251,220,000.00 | -1,563,550,000.00 | 5,814,770,000.00 | 1,104,280,000.00 | 3,146,940,000.00 | 2,378,710,000.00 | 1,800,800,000.00 | 530,980,000.00 | 0.00 | 8,435,750,000.00 | 7,450,000.00 | 12,100,000.00 | 40,300,000.00 | 637,020,000.00 | 2,823,260,000.00 | 125,690,000.00 | 1,220,060,000.00 | 268,740,000.00 | 1,208,770,000.00 | 8,540,000.00 | 4,251,330,000.00 | -77,340,000.00 | 4,328,670,000.00 | 667,850,000.00 | 416,150,000.00 | 251,700,000.00 | 130,970,000.00 | 120,730,000.00 |
| 2024-03-31T00:00:00 | annual | 55,245,966.00 | 55,245,966.00 | 806,570,000.00 | 1,187,920,000.00 | 7,848,660,000.00 | 11,535,550,000.00 | 4,188,380,000.00 | 7,848,660,000.00 | 129,650,000.00 | 10,477,280,000.00 | 10,810,520,000.00 | 10,477,280,000.00 | 0.00 | 10,477,280,000.00 | 35,360,000.00 | 5,645,160,000.00 | 4,686,270,000.00 | 110,490,000.00 | 110,490,000.00 | 5,244,230,000.00 | 996,860,000.00 | 0.00 | 39,840,000.00 | 514,720,000.00 | 442,300,000.00 | 109,060,000.00 | 333,240,000.00 | 39,840,000.00 | 4,247,370,000.00 | 897,690,000.00 | 101,010,000.00 | 745,620,000.00 | 20,590,000.00 | 725,030,000.00 | 49,750,000.00 | 45,230,000.00 | 2,267,200,000.00 | 57,400,000.00 | 18,840,000.00 | 2,190,960,000.00 | 15,721,510,000.00 | 7,285,760,000.00 | 30,000.00 | 92,120,000.00 | 48,100,000.00 | 0.00 | 2,250,000.00 | 120,000.00 | 2,130,000.00 | 250,680,000.00 | 166,680,000.00 | 84,000,000.00 | 2,628,620,000.00 | 1,441,510,000.00 | 1,187,110,000.00 | 4,251,220,000.00 | -1,563,550,000.00 | 5,814,770,000.00 | 1,104,280,000.00 | 3,146,940,000.00 | 2,378,710,000.00 | 1,800,800,000.00 | 530,980,000.00 | 0.00 | 8,435,750,000.00 | 7,450,000.00 | 12,100,000.00 | 40,300,000.00 | 637,020,000.00 | 2,823,260,000.00 | 125,690,000.00 | 1,220,060,000.00 | 268,740,000.00 | 1,208,770,000.00 | 8,540,000.00 | 4,251,330,000.00 | -77,340,000.00 | 4,328,670,000.00 | 667,850,000.00 | 416,150,000.00 | 251,700,000.00 | 130,970,000.00 | 120,730,000.00 |
| 2023-09-30T00:00:00 | quarterly | 55,236,616.00 | 55,236,616.00 | 809,880,000.00 | 1,316,060,000.00 | 7,049,220,000.00 | 11,098,790,000.00 | 3,742,770,000.00 | 7,049,220,000.00 | 0.00 | 9,782,730,000.00 | 10,082,170,000.00 | 9,782,730,000.00 | 0.00 | 9,782,730,000.00 | 9,672,280,000.00 | 0.00 | 0.00 | 110,450,000.00 | 110,450,000.00 | 5,559,910,000.00 | 871,910,000.00 | 0.00 | 0.00 | 544,570,000.00 | 299,440,000.00 | 0.00 | 299,440,000.00 | 27,900,000.00 | 4,688,000,000.00 | 204,420,000.00 | 0.00 | 1,016,620,000.00 | 0.00 | 1,016,620,000.00 | 0.00 | 44,240,000.00 | 2,310,170,000.00 | 0.00 | 116,110,000.00 | 2,194,060,000.00 | 15,342,640,000.00 | 6,911,870,000.00 | 532,300,000.00 | 0.00 | 39,010,000.00 | 0.00 | 29,840,000.00 | 29,840,000.00 | 0.00 | 248,630,000.00 | 0.00 | 0.00 | 2,733,510,000.00 | 1,546,400,000.00 | 1,187,110,000.00 | 3,265,140,000.00 | 0.00 | 3,265,140,000.00 | 242,500,000.00 | 3,022,640,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8,430,770,000.00 | 621,300,000.00 | 12,100,000.00 | 0.00 | 0.00 | 2,828,450,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3,510,000.00 | 4,135,720,000.00 | 0.00 | 0.00 | 829,690,000.00 | 323,510,000.00 | 506,180,000.00 | 0.00 | 0.00 |
| 2023-03-31T00:00:00 | quarterly | 55,155,486.00 | 55,155,486.00 | 47,300,000.00 | 739,280,000.00 | 6,405,340,000.00 | 9,890,940,000.00 | 3,717,050,000.00 | 6,405,340,000.00 | 0.00 | 9,151,660,000.00 | 9,500,990,000.00 | 9,151,660,000.00 | 0.00 | 9,151,660,000.00 | 35,030,000.00 | 4,365,760,000.00 | 4,640,560,000.00 | 110,310,000.00 | 110,310,000.00 | 4,523,990,000.00 | 1,038,910,000.00 | 73,930,000.00 | 21,820,000.00 | 587,200,000.00 | 349,330,000.00 | 0.00 | 349,330,000.00 | 44,900,000.00 | 3,485,080,000.00 | 940,100,000.00 | 84,630,000.00 | 389,950,000.00 | 0.00 | 389,950,000.00 | 43,540,000.00 | 17,430,000.00 | 1,937,370,000.00 | 104,310,000.00 | 22,860,000.00 | 1,810,200,000.00 | 13,675,650,000.00 | 6,473,520,000.00 | 30,000.00 | 86,500,000.00 | 31,990,000.00 | 40,000.00 | 2,140,000.00 | 50,000.00 | 2,090,000.00 | 249,660,000.00 | 161,670,000.00 | 87,990,000.00 | 2,746,320,000.00 | 1,559,210,000.00 | 1,187,110,000.00 | 3,344,570,000.00 | -1,219,630,000.00 | 4,564,200,000.00 | 208,460,000.00 | 3,136,110,000.00 | 2,113,680,000.00 | 1,693,140,000.00 | 548,920,000.00 | 0.00 | 7,202,130,000.00 | 6,340,000.00 | 0.00 | 17,600,000.00 | 263,490,000.00 | 1,884,780,000.00 | 40,340,000.00 | 718,150,000.00 | 135,460,000.00 | 990,830,000.00 | 8,350,000.00 | 3,536,600,000.00 | -41,320,000.00 | 3,577,920,000.00 | 1,484,970,000.00 | 792,990,000.00 | 691,980,000.00 | 572,430,000.00 | 119,550,000.00 |
| 2023-03-31T00:00:00 | annual | 55,155,486.00 | 55,155,486.00 | 47,300,000.00 | 739,280,000.00 | 6,405,340,000.00 | 9,890,940,000.00 | 3,717,050,000.00 | 6,405,340,000.00 | 0.00 | 9,151,660,000.00 | 9,500,990,000.00 | 9,151,660,000.00 | 0.00 | 9,151,660,000.00 | 35,030,000.00 | 4,365,760,000.00 | 4,640,560,000.00 | 110,310,000.00 | 110,310,000.00 | 4,523,990,000.00 | 1,038,910,000.00 | 73,930,000.00 | 21,820,000.00 | 587,200,000.00 | 349,330,000.00 | 0.00 | 349,330,000.00 | 44,900,000.00 | 3,485,080,000.00 | 940,100,000.00 | 84,630,000.00 | 389,950,000.00 | 0.00 | 389,950,000.00 | 43,540,000.00 | 17,430,000.00 | 1,937,370,000.00 | 104,310,000.00 | 22,860,000.00 | 1,810,200,000.00 | 13,675,650,000.00 | 6,473,520,000.00 | 30,000.00 | 86,500,000.00 | 31,990,000.00 | 40,000.00 | 2,140,000.00 | 50,000.00 | 2,090,000.00 | 249,660,000.00 | 161,670,000.00 | 87,990,000.00 | 2,746,320,000.00 | 1,559,210,000.00 | 1,187,110,000.00 | 3,344,570,000.00 | -1,219,630,000.00 | 4,564,200,000.00 | 208,460,000.00 | 3,136,110,000.00 | 2,113,680,000.00 | 1,693,140,000.00 | 548,920,000.00 | 0.00 | 7,202,130,000.00 | 6,340,000.00 | 0.00 | 17,600,000.00 | 263,490,000.00 | 1,884,780,000.00 | 40,340,000.00 | 718,150,000.00 | 135,460,000.00 | 990,830,000.00 | 8,350,000.00 | 3,536,600,000.00 | -41,320,000.00 | 3,577,920,000.00 | 1,484,970,000.00 | 792,990,000.00 | 691,980,000.00 | 572,430,000.00 | 119,550,000.00 |
| 2022-03-31T00:00:00 | annual | 55,056,386.00 | 55,056,386.00 | 0.00 | 84,270,000.00 | 5,446,680,000.00 | 8,135,910,000.00 | 3,146,290,000.00 | 5,446,680,000.00 | 0.00 | 8,051,640,000.00 | 8,051,640,000.00 | 8,051,640,000.00 | 0.00 | 8,051,640,000.00 | 32,850,000.00 | 3,317,720,000.00 | 4,590,960,000.00 | 110,110,000.00 | 110,110,000.00 | 4,515,580,000.00 | 1,568,940,000.00 | 850,270,000.00 | 29,180,000.00 | 689,490,000.00 | 0.00 | 0.00 | 0.00 | 29,180,000.00 | 2,946,640,000.00 | 677,840,000.00 | 71,830,000.00 | 84,270,000.00 | 0.00 | 84,270,000.00 | 19,240,000.00 | 15,990,000.00 | 1,993,130,000.00 | 86,980,000.00 | 44,640,000.00 | 1,861,510,000.00 | 12,567,220,000.00 | 6,474,290,000.00 | 710,000.00 | 39,780,000.00 | 13,530,000.00 | 1,750,000.00 | 3,810,000.00 | 1,750,000.00 | 2,060,000.00 | 241,660,000.00 | 157,120,000.00 | 84,540,000.00 | 2,604,960,000.00 | 1,706,380,000.00 | 898,580,000.00 | 3,511,340,000.00 | -808,320,000.00 | 4,319,660,000.00 | 44,890,000.00 | 441,950,000.00 | 2,055,650,000.00 | 1,670,200,000.00 | 548,920,000.00 | 0.00 | 6,092,930,000.00 | 483,330,000.00 | 0.00 | 0.00 | 485,750,000.00 | 1,899,320,000.00 | 76,050,000.00 | 611,790,000.00 | 115,380,000.00 | 1,096,100,000.00 | 15,070,000.00 | 3,048,530,000.00 | -1,070,000.00 | 3,049,600,000.00 | 644,260,000.00 | 269,490,000.00 | 374,770,000.00 | 82,920,000.00 | 291,850,000.00 |
| 2021-03-31T00:00:00 | annual | 51,929,390.00 | 51,929,390.00 | 0.00 | 0.00 | 3,953,880,000.00 | 4,087,720,000.00 | 2,045,330,000.00 | 3,953,880,000.00 | 0.00 | 4,087,720,000.00 | 4,087,720,000.00 | 4,087,720,000.00 | 0.00 | 4,087,720,000.00 | 21,150,000.00 | 2,387,240,000.00 | 1,575,470,000.00 | 103,860,000.00 | 103,860,000.00 | 1,525,750,000.00 | 23,890,000.00 | 0.00 | 11,010,000.00 | 12,880,000.00 | 0.00 | 0.00 | 0.00 | 11,010,000.00 | 1,501,860,000.00 | 68,820,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10,410,000.00 | 8,240,000.00 | 1,401,570,000.00 | 69,370,000.00 | 21,070,000.00 | 1,311,130,000.00 | 5,613,470,000.00 | 2,066,280,000.00 | 1,090,000.00 | 27,030,000.00 | 3,070,000.00 | 195,230,000.00 | 195,230,000.00 | 195,230,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 133,840,000.00 | 107,600,000.00 | 26,240,000.00 | 1,681,890,000.00 | -482,930,000.00 | 2,164,820,000.00 | 3,190,000.00 | 69,380,000.00 | 1,259,560,000.00 | 731,460,000.00 | 101,230,000.00 | 0.00 | 3,547,190,000.00 | 242,230,000.00 | 0.00 | 0.00 | 248,360,000.00 | 953,540,000.00 | 114,900,000.00 | 311,960,000.00 | 29,030,000.00 | 497,650,000.00 | 21,040,000.00 | 1,440,680,000.00 | -5,290,000.00 | 1,445,970,000.00 | 883,570,000.00 | 731,490,000.00 | 152,080,000.00 | 49,380,000.00 | 102,700,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 377,180,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,710,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NSE: ROSSARI Cash Flow Data In (Cr)
| date | period_type | Free Cash Flow | Repayment Of Debt | Issuance Of Debt | Issuance Of Capital Stock | Capital Expenditure | End Cash Position | Other Cash Adjustment Outside Changein Cash | Beginning Cash Position | Effect Of Exchange Rate Changes | Changes In Cash | Financing Cash Flow | Net Other Financing Charges | Interest Paid Cff | Cash Dividends Paid | Common Stock Dividend Paid | Net Common Stock Issuance | Common Stock Issuance | Net Issuance Payments Of Debt | Net Short Term Debt Issuance | Short Term Debt Payments | Short Term Debt Issuance | Net Long Term Debt Issuance | Long Term Debt Payments | Long Term Debt Issuance | Investing Cash Flow | Net Other Investing Changes | Interest Received Cfi | Dividends Received Cfi | Net Investment Purchase And Sale | Sale Of Investment | Net Business Purchase And Sale | Purchase Of Business | Net PPE Purchase And Sale | Sale Of PPE | Purchase Of PPE | Operating Cash Flow | Taxes Refund Paid | Change In Working Capital | Change In Payable | Change In Inventory | Change In Receivables | Other Non Cash Items | Stock Based Compensation | Provisionand Write Offof Assets | Depreciation And Amortization | Amortization Cash Flow | Depreciation | Pension And Employee Benefit Expense | Gain Loss On Investment Securities | Net Foreign Currency Exchange Gain Loss | Gain Loss On Sale Of PPE | Gain Loss On Sale Of Business | Net Income From Continuing Operations |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | -880,280,000.00 | -115,810,000.00 | 434,800,000.00 | 38,450,000.00 | -1,312,830,000.00 | 251,700,000.00 | 0.00 | 691,980,000.00 | -2,540,000.00 | -437,740,000.00 | 161,850,000.00 | 0.00 | -159,890,000.00 | -27,580,000.00 | -27,580,000.00 | 38,450,000.00 | 38,450,000.00 | 318,990,000.00 | 434,800,000.00 | 0.00 | 434,800,000.00 | -115,810,000.00 | -115,810,000.00 | 0.00 | -1,032,140,000.00 | 0.00 | 26,290,000.00 | 750,000.00 | 376,040,000.00 | 0.00 | -177,330,000.00 | -177,330,000.00 | -1,257,890,000.00 | 54,940,000.00 | -1,312,830,000.00 | 432,550,000.00 | -538,750,000.00 | -1,568,480,000.00 | 496,340,000.00 | -938,480,000.00 | -1,126,340,000.00 | 167,600,000.00 | 6,870,000.00 | 36,020,000.00 | 603,900,000.00 | 211,510,000.00 | 392,390,000.00 | 0.00 | -25,180,000.00 | -5,050,000.00 | -18,780,000.00 | 0.00 | 1,776,150,000.00 |
| 2023-03-31T00:00:00 | annual | 1,186,820,000.00 | 0.00 | 655,010,000.00 | 42,120,000.00 | -328,760,000.00 | 691,980,000.00 | 27,000,000.00 | 374,770,000.00 | 2,020,000.00 | 315,190,000.00 | 608,550,000.00 | 0.00 | -61,050,000.00 | -27,530,000.00 | -27,530,000.00 | 42,120,000.00 | 42,120,000.00 | 655,010,000.00 | 205,850,000.00 | 0.00 | 205,850,000.00 | 449,160,000.00 | 0.00 | 449,160,000.00 | -1,808,940,000.00 | 0.00 | 21,080,000.00 | 1,570,000.00 | -534,370,000.00 | 0.00 | -985,310,000.00 | -985,310,000.00 | -311,910,000.00 | 16,850,000.00 | -328,760,000.00 | 1,515,580,000.00 | -477,770,000.00 | -278,310,000.00 | 400,000.00 | 7,320,000.00 | -286,030,000.00 | 183,260,000.00 | 9,430,000.00 | 20,150,000.00 | 629,310,000.00 | 194,710,000.00 | 434,600,000.00 | 0.00 | -2,710,000.00 | -4,790,000.00 | -2,830,000.00 | 0.00 | 1,442,190,000.00 |
| 2022-03-31T00:00:00 | annual | -88,670,000.00 | -48,120,000.00 | 0.00 | 3,015,050,000.00 | -382,250,000.00 | 374,770,000.00 | 0.00 | 152,080,000.00 | 0.00 | 222,690,000.00 | 2,917,900,000.00 | 0.00 | -21,500,000.00 | -27,530,000.00 | 0.00 | 3,015,050,000.00 | 3,015,050,000.00 | -48,120,000.00 | -48,120,000.00 | -48,120,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | -2,988,790,000.00 | 859,130,000.00 | 49,620,000.00 | 70,000.00 | 874,670,000.00 | 15,540,000.00 | -3,550,010,000.00 | -3,550,010,000.00 | -363,140,000.00 | 19,110,000.00 | -382,250,000.00 | 293,580,000.00 | -501,240,000.00 | -1,120,470,000.00 | -213,340,000.00 | -481,850,000.00 | -425,280,000.00 | 76,460,000.00 | 18,310,000.00 | 8,860,000.00 | 480,550,000.00 | 122,300,000.00 | 358,250,000.00 | 0.00 | -14,250,000.00 | 0.00 | -6,380,000.00 | 0.00 | 1,362,750,000.00 |
| 2021-03-31T00:00:00 | annual | -103,170,000.00 | -610,120,000.00 | 0.00 | 426,530,000.00 | -580,840,000.00 | 152,080,000.00 | 0.00 | 292,110,000.00 | 10,000.00 | -140,040,000.00 | -245,920,000.00 | 2,000,000.00 | -38,950,000.00 | -25,380,000.00 | -25,380,000.00 | 426,530,000.00 | 426,530,000.00 | -610,120,000.00 | -270,520,000.00 | -270,520,000.00 | 0.00 | -339,600,000.00 | -339,600,000.00 | 0.00 | -371,790,000.00 | 58,090,000.00 | 35,220,000.00 | 50,000.00 | 137,220,000.00 | 137,220,000.00 | -43,390,000.00 | -43,390,000.00 | -558,980,000.00 | 21,860,000.00 | -580,840,000.00 | 477,670,000.00 | -313,480,000.00 | -483,050,000.00 | 241,700,000.00 | -320,250,000.00 | -404,500,000.00 | -12,730,000.00 | 16,270,000.00 | 710,000.00 | 228,290,000.00 | 0.00 | 228,290,000.00 | 0.00 | 30,000.00 | -10,000.00 | -4,320,000.00 | -23,020,000.00 | 1,068,380,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -26,480,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | -11,580,000.00 | 249,400,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | -977,790,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4,630,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NSE: ROSSARI Income Statement Data In (Cr)
| date | period_type | Tax Effect Of Unusual Items | Tax Rate For Calcs | Normalized EBITDA | Total Unusual Items | Total Unusual Items Excluding Goodwill | Net Income From Continuing Operation Net Minority Interest | Reconciled Depreciation | Reconciled Cost Of Revenue | EBITDA | EBIT | Net Interest Income | Interest Expense | Interest Income | Normalized Income | Net Income From Continuing And Discontinued Operation | Total Expenses | Rent Expense Supplemental | Diluted Average Shares | Basic Average Shares | Diluted EPS | Basic EPS | Diluted NI Availto Com Stockholders | Net Income Common Stockholders | Otherunder Preferred Stock Dividend | Net Income | Minority Interests | Net Income Including Noncontrolling Interests | Net Income Continuous Operations | Tax Provision | Pretax Income | Other Non Operating Income Expenses | Special Income Charges | Other Special Charges | Write Off | Restructuring And Mergern Acquisition | Net Non Operating Interest Income Expense | Interest Expense Non Operating | Interest Income Non Operating | Operating Income | Operating Expense | Other Operating Expenses | Depreciation And Amortization In Income Statement | Amortization | Depreciation Income Statement | Selling General And Administration | Selling And Marketing Expense | General And Administrative Expense | Rent And Landing Fees | Gross Profit | Cost Of Revenue | Total Revenue | Operating Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | 1.17 | 0.00 | 252.93 | 4.45 | 4.45 | 130.69 | 60.39 | 1,304.07 | 257.38 | 196.99 | -17.13 | 19.37 | 2.24 | 127.42 | 130.69 | 1,642.47 | 6.70 | 5.53 | 5.52 | 0.00 | 0.00 | 130.69 | 130.69 | 0.00 | 130.69 | 0.00 | 130.69 | 130.69 | 46.93 | 177.62 | 0.73 | 1.88 | -1.88 | 0.00 | 0.00 | -17.13 | 19.37 | 2.24 | 182.72 | 338.40 | 69.37 | 60.39 | 21.15 | 39.24 | 81.33 | 64.36 | 16.97 | 6.70 | 521.12 | 1,304.07 | 1,825.19 | 1,825.19 |
| 2023-03-31T00:00:00 | annual | 0.25 | 0.00 | 228.48 | 0.99 | 0.99 | 107.26 | 62.93 | 1,178.46 | 229.47 | 166.53 | -19.79 | 22.32 | 2.52 | 106.52 | 107.26 | 1,499.69 | 5.32 | 5.54 | 5.51 | 0.00 | 0.00 | 107.26 | 107.26 | 0.00 | 107.26 | 0.00 | 107.26 | 107.26 | 36.96 | 144.22 | 1.97 | 0.28 | -0.28 | 0.00 | 0.00 | -19.79 | 22.32 | 2.52 | 151.63 | 321.23 | 60.19 | 62.93 | 19.47 | 43.46 | 82.84 | 67.50 | 15.34 | 5.32 | 472.86 | 1,178.46 | 1,651.32 | 1,651.32 |
| 2022-03-31T00:00:00 | annual | 0.32 | 0.00 | 195.87 | 1.12 | 1.12 | 97.67 | 48.06 | 1,113.54 | 196.99 | 148.93 | -8.59 | 12.66 | 4.07 | 96.87 | 97.67 | 1,345.00 | 4.67 | 5.52 | 5.48 | 0.00 | 0.00 | 97.67 | 97.67 | 0.00 | 97.67 | -0.02 | 97.70 | 97.70 | 38.58 | 136.28 | 5.82 | -0.30 | -0.64 | 0.94 | 0.00 | -8.59 | 12.66 | 4.07 | 130.17 | 231.47 | 39.53 | 48.06 | 12.23 | 35.83 | 63.49 | 48.37 | 15.12 | 4.67 | 361.64 | 1,113.54 | 1,475.18 | 1,475.18 |
| 2021-03-31T00:00:00 | annual | 0.68 | 0.00 | 129.93 | 2.73 | 2.73 | 80.22 | 22.83 | 465.06 | 132.66 | 109.83 | 1.27 | 2.99 | 4.27 | 78.18 | 80.22 | 607.17 | 3.66 | 5.19 | 5.16 | 0.00 | 0.00 | 80.22 | 80.22 | 0.00 | 80.22 | 0.17 | 80.05 | 80.05 | 26.79 | 106.84 | 1.70 | 2.73 | -0.43 | 0.00 | -2.30 | 1.27 | 2.99 | 4.27 | 100.24 | 142.11 | 18.83 | 22.83 | 1.70 | 21.13 | 43.16 | 34.74 | 8.42 | 3.66 | 242.35 | 465.06 | 707.41 | 707.41 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
FII & DII Data (In Cr)
| Date | FII Gross Purchase | FII Gross Sales | FII Net Purchase / Sales | DII Gross Purchase | DII Gross Sales | DII Net Purchase / Sales |
|---|---|---|---|---|---|---|
| 2025-02-03 | 12,505.92 | 16,464.29 | -3,958.37 | 19,319.48 | 16,611.25 | 2,708.23 |
| 2025-01-30 | 10,513.63 | 15,096.58 | -4,582.95 | 13,934.35 | 11,768.46 | 2,165.89 |
| 2025-01-29 | 7,644.40 | 10,230.83 | -2,586.43 | 12,871.38 | 11,078.67 | 1,792.71 |
| 2025-01-27 | 9,488.57 | 14,504.03 | -5,015.46 | 16,503.43 | 9,861.28 | 6,642.15 |
| 2025-01-24 | 11,230.47 | 13,988.96 | -2,758.49 | 12,835.41 | 10,433.10 | 2,402.31 |
| 2025-01-23 | 13,316.55 | 18,779.07 | -5,462.52 | 14,412.73 | 10,700.18 | 3,712.55 |
| 2025-01-22 | 12,936.64 | 16,962.89 | -4,026.25 | 15,437.18 | 11,796.96 | 3,640.22 |
Piotroski F-Score
5/9
0
1
2
3
4
5
6
7
8
9
Key Metrics
EPS
25.07
P/E
31.47188
P/B
3.9032934
Dividend Yield
0.06%
Market Cap
4,367.61 Cr.
Face Value
202.137
Book Value
202.137
ROE
7.21%
EBITDA Growth
250.60 Cr.
Debt/Equity
14.385
Short Term
Subscribe to unlock this feature
Medium Term
Subscribe to unlock this feature
Long Term
Subscribe to unlock this feature
Yearly Stock Performance Heatmap
Latest Updates
Ashoka Buildcon Arm Signs Rs 1,391 Crore Pact With NHAI
Ashoka Buildcon Ltd. announced on Monday, via an exchange filing, that its wholly owned subsidiary, Ashoka Bowaichandi Guskara Road Pvt Ltd., has exec...
Budget 2025: Rahul Bajoria On Addressing Income Growth And Consumption Trends
"However, discretionary, high-value consumption is taking a step back due to income growth settling at high single digits." Over the past fe...
FPIs Stay Net Sellers, Sell Stocks Worth Rs 2,575 Crore
Foreign portfolio investors stayed net sellers for the second straight session on Monday and sold stocks worth approximately Rs 2,575.1 crore, accordi...
Budget 2025: AMFI Seeks Tax Policy Reforms To Drive Mutual Fund Investments In 15-Point Proposal
The Association of Mutual Funds of India on Monday released a 15-point proposal for Union Budget 2025-26 requesting changes in tax policies that are i...
Apple iPhone SE 4: Price To Features, 11 Things You Need To Know
iPhone 16e (Not iPhone SE 4): If recent reports are to be believed, Apple may discontinue the SE label and rename iPhone SE 4 as iPhone 16e. Most Affo...
Rupee Closed Weaker Against The US Dollar
The rupee weakened by five paise to close at 85.83 against the US dollar. The Indian rupee had declined to a fresh low against the US dollar during th...
Table Space Founder Amit Banerji Dies Of Heart Attack At Age Of 45
Amit Banerji, the founder, chairman and chief executive officer of managed workspace provider Table Space, died after suffering from a heart attack, r...
War Fatigue, Economic Breakdown Or Pro-West? Why Syria's Al-Sharaa Is Seen Soft On Israel
The strategic positions have been used by Israeli forces to carry out hundreds of strikes to destroy Syria's military infrastructure. In 2011, be...
Popular Questions
What is the Market Cap of rossari?
The market capitalization of Rossari Biotech Limited is ₹4,368 Cr as of 05 Feb 2025.
What are the PE and PB ratios of Rossari Biotech Limited?
The PE and PB ratios of Rossari Biotech Limited are Not Available and 3.9032934 respectively as of 05 Feb 2025.
What is the 52 Week High of Rossari Biotech Limited?
The 52-week high of Rossari Biotech Limited is ₹972.7 as of 05 Feb 2025.
What is the 52 Week Low of Rossari Biotech Limited?
The 52-week low of Rossari Biotech Limited is ₹656.95 as of 05 Feb 2025.
What are the earnings per share (EPS) for Rossari Biotech Limited?
The Earnings Per Share (EPS) of Rossari Biotech Limited is ₹25.07 as per the most recent quarterly results available on Fincept.
What is the ROE (Return on Equity) of Rossari Biotech Limited?
The Return on Equity (ROE) of Rossari Biotech Limited is 7.21% as per the most recent financial year data. Explore more on Fincept.